CLPBF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Coloplast A/S

Watchlist Manager

Watchlist

Price: 71.24 USD 1.74% Market Closed

Market Cap: $16B

C	Coloplast A/S OTC:CLPBF	DK
E	Empress Royalty Corp OTC:EMPYF	CA
G	GoDaddy Inc F:38D	US
	Core Assets Corp OTC:CCOOF	CA
T	Teva Pharmaceutical Industries Ltd SWB:TEV	IL
	Astra Agro Lestari Tbk PT IDX:AALI	ID
B	Battery Age Minerals Ltd ASX:BM8	AU

Profitability Summary

Coloplast A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

67%

Gross Margin is Increasing

67% > 67%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

27%

Declining Operating Margin

28% > 27%

Low Net Margin

10%

Sustainable 3Y Average Net Margin

15%

Declining Net Margin

20% > 10%

Exceptional Free Cash Flow Margin

22%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

12% > 22%

Positive ROE

19%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

12%

Declining ROIC

14% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.